4-氯-7-氟-6-硝基喹唑啉

4-Chloro-7-fluoro-6-nitroquinazoline is an intermediate in the synthesis of Afatinib, an aminocrotonylamino-substituted quinazoline derivative used for treating cancer and diseases of the respiratory tract, lungs, gastrointestinal tract, bile duct, and gallbladder.